Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China · Delayed Price · Currency is CNY 30.85
-0.32 (-1.03%)
Aug 14, 2026, 3:00 PM CST
SHA:688321 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 581.26 | 347.75 | 375.55 | 375.9 | 508.98 | 300.55 |
Short-Term Investments | - | - | - | 257.52 | 181.6 | 100.09 |
Trading Asset Securities | 933.01 | 295.3 | 94.13 | 216.72 | 291.07 | 82.08 |
Cash & Short-Term Investments | 1,514 | 643.05 | 469.69 | 850.14 | 981.65 | 482.71 |
Cash Growth | 201.38% | 36.91% | -44.75% | -13.40% | 103.36% | -31.19% |
Accounts Receivable | 309.34 | 299.79 | 162.97 | 196.82 | 154.81 | 111.44 |
Other Receivables | 7.8 | 4.97 | 13 | 21.71 | 11.62 | 9.17 |
Receivables | 317.14 | 304.76 | 175.97 | 218.53 | 166.43 | 120.62 |
Inventory | 58.43 | 57.68 | 40.84 | 47.13 | 28.47 | 15.37 |
Prepaid Expenses | - | - | - | - | - | 1.69 |
Other Current Assets | 174.64 | 174.9 | 396.97 | 14.29 | 7.58 | 18.43 |
Total Current Assets | 2,064 | 1,180 | 1,083 | 1,130 | 1,184 | 638.82 |
Property, Plant & Equipment | 1,336 | 1,293 | 1,158 | 1,066 | 1,100 | 698.99 |
Long-Term Investments | 223.46 | 228.86 | 245.63 | 268.94 | 29.83 | - |
Other Intangible Assets | 410.14 | 417.82 | 448.29 | 183.99 | 202.8 | 216.18 |
Long-Term Deferred Tax Assets | 2.85 | 2.9 | 1.53 | 2.08 | 24.67 | 22.03 |
Long-Term Deferred Charges | 290.28 | 255.64 | 168.3 | 403.8 | 270.53 | 145.93 |
Other Long-Term Assets | 254.77 | 271.78 | 146.14 | 148.27 | 83.81 | 172.46 |
Total Assets | 4,582 | 3,650 | 3,251 | 3,203 | 2,896 | 1,894 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 5.53 | 3.78 | 2.19 | 9.03 | 0.32 | 2.23 |
Accrued Expenses | 23.31 | 177.5 | 142.03 | 120.2 | 77.4 | 65.82 |
Short-Term Debt | 148.47 | 159.8 | 100.22 | 130.11 | 185.78 | 120.15 |
Current Portion of Long-Term Debt | 342.63 | 342.79 | 133.66 | 36.19 | 19.88 | 17.92 |
Current Portion of Leases | - | 3.33 | 3.54 | 2.84 | 2.89 | 4.76 |
Current Income Taxes Payable | 14.9 | - | - | 0.17 | 12.07 | 10.77 |
Current Unearned Revenue | 1.1 | 0.15 | 0.17 | 0.08 | 0.23 | 0.29 |
Other Current Liabilities | 269.23 | 156.55 | 69.5 | 92.18 | 241.96 | 71.89 |
Total Current Liabilities | 805.16 | 843.9 | 451.31 | 390.81 | 540.54 | 293.84 |
Long-Term Debt | 1,048 | 1,035 | 1,088 | 899.17 | 598.02 | 4.88 |
Long-Term Leases | 4.12 | 4.89 | 7.76 | 10.06 | 1.29 | 1.42 |
Long-Term Unearned Revenue | 100.31 | 101.4 | 83.35 | 77.04 | 86.96 | 78.94 |
Long-Term Deferred Tax Liabilities | 39.18 | 38.88 | 38.96 | 23.45 | - | - |
Other Long-Term Liabilities | 0.15 | 0.16 | 0 | 92.83 | 93.29 | 97.71 |
Total Liabilities | 1,997 | 2,025 | 1,670 | 1,493 | 1,320 | 476.79 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 442.94 | 407.81 | 407.8 | 411.29 | 410.72 | 410.72 |
Additional Paid-In Capital | 1,921 | 1,023 | 1,013 | 1,138 | 1,075 | 1,125 |
Retained Earnings | 107.49 | 79.22 | 28.26 | 142.83 | 53.99 | 36.51 |
Treasury Stock | -17 | -15 | - | -113.07 | -154.59 | -154.59 |
Comprehensive Income & Other | 130.12 | 130.8 | 131.84 | 131.09 | 130.05 | -0.29 |
Total Common Equity | 2,585 | 1,626 | 1,581 | 1,710 | 1,515 | 1,418 |
Minority Interest | - | - | - | - | 60.23 | - |
Shareholders' Equity | 2,585 | 1,626 | 1,581 | 1,710 | 1,576 | 1,418 |
Total Liabilities & Equity | 4,582 | 3,650 | 3,251 | 3,203 | 2,896 | 1,894 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,544 | 1,546 | 1,334 | 1,078 | 807.87 | 149.14 |
Net Cash (Debt) | -29.37 | -903.19 | -863.9 | -228.24 | 173.78 | 333.58 |
Net Cash Growth | - | - | - | - | -47.90% | -48.17% |
Net Cash Per Share | -0.07 | -2.22 | -2.12 | -0.56 | 0.43 | 0.81 |
Filing Date Shares Outstanding | 442.34 | 442.34 | 407.8 | 409.01 | 406.97 | 406.97 |
Total Common Shares Outstanding | 442.34 | 407.27 | 407.8 | 409.01 | 406.97 | 406.97 |
Working Capital | 1,259 | 336.49 | 632.16 | 739.28 | 643.59 | 344.98 |
Book Value Per Share | 5.84 | 3.99 | 3.88 | 4.18 | 3.72 | 3.48 |
Tangible Book Value | 2,174 | 1,208 | 1,133 | 1,526 | 1,313 | 1,201 |
Tangible Book Value Per Share | 4.92 | 2.97 | 2.78 | 3.73 | 3.23 | 2.95 |
Buildings | - | 908.16 | 745.57 | 656.92 | 722.9 | 471.88 |
Machinery | - | 160.2 | 118.55 | 108.28 | 112.93 | 90.43 |
Construction In Progress | - | 351.4 | 384.86 | 360.81 | 308.1 | 157.75 |